ST
CYTK icon

Stifel Trust’s Cytokinetics CYTK Stock Holding History

Stifel Trust’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$4K Hold
1,025
– – ﹤0.01% 489
2014
Q2 		$5K Hold
1,025
– – ﹤0.01% 414
2014
Q1 		$10K Hold
1,025
– – ﹤0.01% 393
2013
Q4 		$7K Buy
+1,025
New +$6.73K ﹤0.01% 404

Other funds holding CYTK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
IIM
Ironwood Investment Management Boston, Massachusetts $240M AUM 45.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Stifel Trust's CYTK Position: Q3 2014 in Review

Stifel Trust held its Cytokinetics (CYTK) position steady in Q3 2014 at 1,025 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #489.

Stifel Trust first reported a position in CYTK in Q4 2013 and has held it in 4 quarters since. The position peaked at $10K in Q1 2014. 85 funds tracked by Wall St. Rank hold CYTK as of Q3 2014.

  • Stifel Trust held 1,025 shares of Cytokinetics worth $4K as of Q3 2014.
  • Stifel Trust left its Cytokinetics share count unchanged in Q3 2014.
  • Cytokinetics made up ﹤0.01% of Stifel Trust's portfolio in Q3 2014, its #489 holding.
  • Stifel Trust first reported a position in Cytokinetics in Q4 2013 and has held it in 4 quarters since.
  • Stifel Trust's Cytokinetics position peaked at $10K in Q1 2014.
  • 85 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2014.

Based on Stifel Trust's 13F filing for Q3 2014, filed 14 Nov 2014.